These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21494636)

  • 21. Dampening of CD8+ T Cell Response by B Cell Depletion Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Néel A; Bucchia M; Néel M; Tilly G; Caristan A; Yap M; Rimbert M; Bruneau S; Cadoux M; Agard C; Hourmant M; Godmer P; Brouard S; Bressollette C; Hamidou M; Josien R; Fakhouri F; Degauque N
    Arthritis Rheumatol; 2019 Apr; 71(4):641-650. PubMed ID: 30375745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent deficiency of circulating mucosal-associated invariant T (MAIT) cells in ANCA-associated vasculitis.
    Braudeau C; Amouriaux K; Néel A; Herbreteau G; Salabert N; Rimbert M; Martin JC; Hémont C; Hamidou M; Josien R
    J Autoimmun; 2016 Jun; 70():73-9. PubMed ID: 27102145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.
    Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I
    Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission.
    Söderberg D; Kurz T; Motamedi A; Hellmark T; Eriksson P; Segelmark M
    Rheumatology (Oxford); 2015 Nov; 54(11):2085-94. PubMed ID: 26170375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2.
    Berntsen A; Brimnes MK; thor Straten P; Svane IM
    J Immunother; 2010 May; 33(4):425-34. PubMed ID: 20386464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photo(chemo)therapy reduces circulating Th17 cells and restores circulating regulatory T cells in psoriasis.
    Furuhashi T; Saito C; Torii K; Nishida E; Yamazaki S; Morita A
    PLoS One; 2013; 8(1):e54895. PubMed ID: 23365685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring Frequencies of Circulating Specific Th17 Cells against Myeloperoxidase and Proteinase 3 in ANCA Associated Vasculitis.
    Martinez Valenzuela L; Draibe J; Quero M; Fulladosa X; Cruzado JM; Bestard O; Torras J
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia.
    Darmochwal-Kolarz D; Kludka-Sternik M; Tabarkiewicz J; Kolarz B; Rolinski J; Leszczynska-Gorzelak B; Oleszczuk J
    J Reprod Immunol; 2012 Mar; 93(2):75-81. PubMed ID: 22370101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in circulating lymphoid cell populations in systemic small vessel vasculitis are non-specific manifestations of renal injury.
    Fazekas B; Moreno-Olivera A; Kelly Y; O'Hara P; Murray S; Kennedy A; Conlon N; Scott J; Melo AM; Hickey FB; Dooley D; O'Brien EC; Moran S; Doherty DG; Little MA
    Clin Exp Immunol; 2018 Feb; 191(2):180-188. PubMed ID: 28960271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum interleukin-21 positivity could indicate the current activity of antineutrophil cytoplasmic antibody-associated vasculitis: a monocentric prospective study.
    Yoon T; Ahn SS; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2019 Jun; 38(6):1685-1690. PubMed ID: 30863949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary and serum soluble CD25 complements urinary soluble CD163 to detect active renal anti-neutrophil cytoplasmic autoantibody-associated vasculitis: a cohort study.
    Dekkema GJ; Abdulahad WH; Bijma T; Moran SM; Ryan L; Little MA; Stegeman CA; Heeringa P; Sanders JF
    Nephrol Dial Transplant; 2019 Feb; 34(2):234-242. PubMed ID: 29506265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
    Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
    Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor Necrosis Factor-producing T-regulatory Cells Are Associated With Severe Liver Injury in Patients With Acute Hepatitis A.
    Choi YS; Jung MK; Lee J; Choi SJ; Choi SH; Lee HW; Lee JJ; Kim HJ; Ahn SH; Lee DH; Kim W; Park SH; Huh JR; Kim HP; Park JY; Shin EC
    Gastroenterology; 2018 Mar; 154(4):1047-1060. PubMed ID: 29229400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors.
    Sun J; Lundström SL; Zhang B; Zubarev RA; Steuer J; Gillgren P; Rahman M; Ajeganova S; Liu A; Frostegård J
    Atherosclerosis; 2018 Jan; 268():36-48. PubMed ID: 29175653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection.
    Xue-Song L; Cheng-Zhong L; Ying Z; Mo-Bin W
    BMC Gastroenterol; 2012 May; 12():43. PubMed ID: 22548790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?
    Wilde B; Thewissen M; Damoiseaux J; van Paassen P; Witzke O; Tervaert JW
    Arthritis Res Ther; 2010; 12(1):204. PubMed ID: 20236453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirolimus selectively increases circulating Treg cell numbers and restores the Th17/Treg balance in rheumatoid arthritis patients with low disease activity or in DAS28 remission who previously received conventional disease-modifying anti-rheumatic drugs.
    Niu HQ; Li ZH; Zhao WP; Zhao XC; Zhang C; Luo J; Lu XC; Gao C; Wang CH; Li XF
    Clin Exp Rheumatol; 2020; 38(1):58-66. PubMed ID: 31074719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased CD4
    Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
    World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.